Alexander Craeymeersch's questions to Materialise NV (MTLS) leadership • Q2 2025
Question
Alexander Craeymeersch from Kepler Cheuvreux asked about the sustainability of double-digit growth in the Medical segment, the specific factors leading to the revised top-line guidance, and the volume versus price dynamics in the Manufacturing segment.
Answer
CEO Brigitte de Vet-Veithen expressed confidence in the continued growth of the Medical segment for the next couple of years, noting the mix between existing and new markets may shift but the overall growth trajectory is positive. She explained the guidance revision was a detailed, bottom-up forecast based on trends in specific business lines, not a single parameter. CFO Koen Berges addressed the Manufacturing segment, stating the revenue decline was a volume effect and that protecting margins is challenging due to semi-fixed costs, which the company is actively working to reduce.